Jan 15, 2026 07:05AM

May 8, 2025 04:01PM

Jan 2, 2025 12:51PM

Aug 22, 2024 07:01AM

Aug 22, 2024 07:00AM

Aug 9, 2024 05:59PM

Jul 24, 2024 07:31AM Skye Bioscience (SKYE) and Beacon Biosignals Collaborate to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND Phase 2 Trial

Jul 24, 2024 07:30AM

Jul 24, 2024 06:00AM

Jan 29, 2024 08:02AM

Jan 29, 2024 08:00AM

Jan 9, 2024 07:00AM

Dec 11, 2023 07:00AM

Jul 6, 2023 07:00AM Skye Bioscience Completes Production and Filling of Investigational Drug Material in Preparation for Phase 2a Glaucoma Clinical Trial

Apr 27, 2023 07:00AM

Jan 27, 2023 07:00AM

Jan 24, 2023 08:00AM

Dec 20, 2022 07:03AM

Dec 20, 2022 07:00AM

Dec 16, 2022 07:00AM

Nov 17, 2022 07:00AM Skye Bioscience Submits Investigational New Drug Application for SBI-100 Ophthalmic Emulsion to FDA

Nov 10, 2022 10:48PM

Sep 30, 2022 03:24PM

Aug 19, 2022 03:22PM

Aug 19, 2022 02:12PM

Jul 21, 2022 07:00AM

Jul 20, 2022 07:00AM

Jun 30, 2022 07:02AM Skye Bioscience (SKYE) Granted Australian Ethics Committee Approval to Start First-in-Human Phase 1 Study of SBI-100

Jun 30, 2022 07:00AM

Jan 10, 2022 07:00AM

Apr 22, 2021 08:30AM

Mar 16, 2021 08:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All